Canntab Therapeutics Ltd C.PILL

Alternate Symbol(s): CTABF

Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and consumers with medical grade solutions. These include once a day and extended-release formulations. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet (ODT). The IR Tablet is a release profile for solid hard tablets. The XR Tablet is a phytocannabinoid vehicle that is designed to directly address the drawbacks and challenges of competing oral delivery systems. ODT is specifically designed to dissolve directly in the patient’s mouth, with an onset of action between five and thirty minutes.

CSE:PILL - Post by User

Canntab Therapeutics Ltd

<< Previous

Bullboard Posts

Next >>

Post by hinne66on Apr 27, 2018 9:47am

52 Views

Post# 27949382

Recent Bulletins from 04-18 to date

Date ET	Symbol	Ex	Price	Type	Headline
2018-04-27 09:20	C:PILL		0.72	News Release	CSE New Listing - Canntab Therapeutics Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com
2018-04-26 10:39	C:PILL		0.73	News Release	Canntab files four new patent applications
2018-04-24 10:54	C:PILL		0.55	News Release	Canntab hires Moore for dealer licence application
2018-04-19 13:15	C:PILL			News Release	Canntab Therapeutics to trade on CSE April 20
2018-04-18 15:26	C:PILL			New Listing	Telferscot name change to Canntab Therapeutics